Crossmark

Novel Phenoxazinones as potent agonist of PPAR-α: design, synthesis, molecular docking and in vivo studies

Crossref DOI link: https://doi.org/10.1186/s12944-018-0764-y

Published Online: 2018-05-22

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ugwu, David I.

Okoro, Uchechukwu C.

Mishra, Narendra K.

Okafor, Sunday N.
License Information

Text and Data Mining valid from 2018-05-22
More Information

Article History

Received: 3 December 2017

Accepted: 30 April 2018

First Online: 22 May 2018

Ethics approval

: The use and care for animal used in the study was approved by the University of Nigeria ethical committee.

: All the authors approved the submission of the manuscript to Lipid in Health and Disease for onward publication after peer-review processes.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.